Oxazolyl-aryloxyacetic acid derivatives and their use as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S236000

Reexamination Certificate

active

10343187

ABSTRACT:
Novel compounds that are modulators of PPAR receptors, and pharmaceutically acceptable salts, solvates and hydrates thereof, processes for making the compounds, pharmaceutical compositions containing the compounds, or pharmaceutically acceptable salts, solvates and hydrates thereof

REFERENCES:
patent: 5089514 (1992-02-01), Hulin
patent: 5232945 (1993-08-01), Hulin
patent: 5306726 (1994-04-01), Hulin
patent: 5902726 (1999-05-01), Kliewer et al.
patent: 5994554 (1999-11-01), Kliewer et al.
patent: 0 930 299 (1999-07-01), None
patent: 2 359 082 (2001-08-01), None
patent: WO 97 28115 (1997-08-01), None
patent: WO 97 31907 (1997-09-01), None
patent: WO 99 46232 (1999-09-01), None
patent: WO 01 16120 (2001-03-01), None
patent: WO 02 16331 (2002-02-01), None
patent: WO 02 18355 (2002-03-01), None
Sarges, R., et al. : “Glucose Transport—Enhancing and Hypoglycemic Activity of 2-Methyl-2-Phenoxy-3-Phenylpropanoic Acids”; Journal of Medicinal Chemistry, vol. 39, No. 24, Nov. 22, 1996, pp. 4783-4803.
Cobb, J. E., et al. : “N-(2-Benzoylphenyl) -L-Tyrosine PPARGamma Agonists. 3.Structure-Activity Relationship and Optimization of the N-Aryl Substituent”; Journal of Medicinal Chemistry, vol. 41, No. 25, Dec. 3, 1998, pp. 5055-5069.
Bright, S.W., et al. : “Competitive Particle Concentration Fluorescence Immunoassays for Measuring Anti-Diabetic Drug Levels in Mouse Plasma”; Journal of Immunological Methods, vol. 207, No. 1, Aug. 22, 1997 (Aug. 2, 1997), pp. 23-31.
Brooks, D., et al. : “Design and Synthesis of 2-methyl-2-{4-′2-′5-methyl-2-aryloxazol-4-yl)ethoxylphenoxy}propionic acids: A New Class of Dual PPARAlpha/Gamma Agonists”; Journal of Medicinal Chemistry, vol. 44, No. 13, Jun. 21, 2001, pp. 2061-2064.
Shinkai, H. et al. : “Isoxazolidine-3, 5-dione and Noncyclic 1, 3-dicarbonyl Compounds as Hypoglycemic Agents”; Journal of Medicinal Chemistry, vol. 41, No. 11, May 21, 1998, pp. 1927-1933.
Murugesan, N., et al. : “Biphenylsulfonamide Endothelin Receptor Antogonists 2. Discovery of 4′-oxazoly-lbiphenylsulfonamides as a New Class of Poent, Highly Selective ET(A)Antagonists”; Journal of Medicinal Chemistry, vol. 43, No. 16, Aug. 10, 2000, pp. 3111-3117.
Malamas, M.S., et al. : “Azole Phenoxy Hydroxyureas as Selective and Orally Active Inhibitors fo 5-Lipoxygenase”; Journal of Medicinal Chemistry, vol. 39, No. 1, Jan. 5, 1996, pp. 237-245.
Merguro, K., et al. : “Studies on Antidiabetic Agents. VII. Synthesis and Hypoglycemic Activity fo 4-Oxazoleacetic Acid Derivatives”; Chemical & Pharmaceutical Bulletin, vol. 34, No. 7, 1986, pp. 2840-2851.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oxazolyl-aryloxyacetic acid derivatives and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxazolyl-aryloxyacetic acid derivatives and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolyl-aryloxyacetic acid derivatives and their use as... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3894856

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.